DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 104 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,375,000 | -8.8% | 235,000 | 0.0% | 0.86% | +12.0% |
| Q2 2019 | $3,701,000 | -72.3% | 235,000 | -81.2% | 0.77% | -84.2% |
| Q4 2018 | $13,363,000 | -20.4% | 1,250,000 | +13.6% | 4.85% | +35.9% |
| Q3 2018 | $16,786,000 | +107.6% | 1,100,000 | +66.7% | 3.57% | +50.0% |
| Q2 2018 | $8,085,000 | -11.0% | 660,000 | -30.5% | 2.38% | +29.5% |
| Q1 2018 | $9,082,000 | +101.2% | 950,000 | +90.0% | 1.84% | +73.5% |
| Q4 2017 | $4,515,000 | – | 500,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |